Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials
Protein kinase C (PKC), a family of phospholipid-dependent serine/threonine kinase, is classed into three subfamilies based on their structural and activation characteristics: conventional or classic PKC isozymes (cPKCs; α, βI, βII, and γ), novel or non-classic PKC isozymes (nPKCs; δ, ε, η, and θ),...
Enregistré dans:
Auteurs principaux: | Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, Masaharu Murata, Jeong-Hun Kang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f14f609da4c24b3a97c0233460bc6c6b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors
par: Momen R. Fareed, et autres
Publié: (2021) -
New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity
par: Francisco José Aguilar-Troyano, et autres
Publié: (2021) -
Recent Progress in Development of Polo-Like Kinase 1 Inhibitors: Efforts So Far
par: Ramesh L. Sawant, et autres
Publié: (2021) -
Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells
par: Joelle C. Boulos, et autres
Publié: (2021) -
Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
par: Sareshma Sudhesh Dev, et autres
Publié: (2021)